Abstract
We aimed to assess expression of genes encoding the heterodimeric IL-27 cytokine and constituent subunits of the Il-27 receptor in rheumatoid arthritis (RA), including in extra-articular, subcutaneous rheumatoid nodules. Comparing between nodules and joint synovia, significantly elevated expression of IL27A within nodules, and comparable IL27B expression, identified nodules as a significant source of IL-27 in RA. T-lymphocytes were the main source of IL27RA transcript, and IL27RA expression correlated with a number of plasma cytokines, as well as tissue TNF expression in both nodules and RA synovia. In synovia, correlations between IL27A, IL27RA IL17A and CD21L expression, and significantly elevated expression of the genes encoding IL-27, associated the presence of IL-27 with B cell-dominated synovial inflammation. Impact from nodule derived IL-27 on systemic or synovial inflammation in RA remains unknown and further study of these implications is required. Our study raises questions regarding the appropriate circumstances for the blockade or administration of IL-27 as a potential therapeutic adjunct in RA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bastian D, Wu Y, Betts BC, Yu XZ. The IL-12 cytokine and receptor family in graft-vs-host disease. Front Immunol. 2019;10:988. https://doi.org/10.3389/fimmu.2019.00988.
Stumhofer JS, Tait ED, Quinn WJ, Hosken N, Spudy B, Goenka R, et al. A role for Il-27p28 as an antagonist of gp130-mediated signalling. Nat Immunol. 2010;11:1119–26.
Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Hibbert L, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naïve CD4+ T cells. Immunity. 2002;16:779–90.
Petes C, Mariani MK, Yang Y, Grandvaux N, Gee K. Interleukin (IL)-6 inhibits IL-27- and IL-30-mediated inflammatory responses in human monocytes. Front Immunol. 2018;9:256. https://doi.org/10.3389/fimmu.2018.00256.
Muller SI, Friedl A, Aschenbrenner I, Esser-von Bieren J, Zacharias M, Devergne O, et al. A folding switch regulates interleukin biogenesis and secretion of it α-subunit as a cytokine. Proc Nat Acad Sci USA. 2019;116:1585–90.
Laroni A, Gandhi R, Beynon V, Weiner HL. IL-27 imparts immunoregulatory function to human NK cells subsets. PLoS ONE. 6:e26173. https://doi.org/10.1371/journal.pone.0026173.
Jankowski M, Kopinski P, Goc A. Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp. 2010;58:417–25.
Wong CK, Chen DP, Tam LS, Li EK, Yin YB, Lam CW. Effects of inflammatory cytokineIL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arth Res Ther. 2010;12:R129.
Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralising the function of the p28 subunit of IL-27. J Immunol. 2004;173:1171–8.
Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med. 2015;212:1793–802.
Shen H, Xia L, Xiao W, Lu J. Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arth Rheum. 2011;63:860–1.
Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata, Shibuya H, et al. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. Cytokine. 2011;55:237–44.
Baker KF, Skelton AJ, Lendrem DW, Scadeng A, Thompson B, Pratt AG, et al. Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study. J Autoimmun. 2019;105:102298.
Hessian PA, Highton J, Kean A, Sun CK, Chin M. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arth Rheum. 2003;48:334–8.
Dorosz SA, Ginolhac A, Kahne T, Naumann M, Salamann Sauter T. et al. Role of calprotectin as a modulator of the IL27-mediated proinflammatory effect on endothelial cells. Mediators Inflamm. 2015;2015:737310.
McKelvey KJ, Millier MJ, Doyle TC, Stamp LK, Highton J, Hessian PA. Co-expression of CD21l and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation. PLoS ONE. 2018;16:e0202135.
Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6:e1.
Palmer DG, Hogg N, Denholm I, Allen CA, Highton J, Hessian PA. Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules. Rheumatol Int. 1987;7:187–93.
Soni S, O’Dea KP, Tan YY, Cho K, Abe E, Romano R, et al. ATP directs cytokine trafficking and promotes novel membrane TNF signalling via micro-vesicles. FASEB J. 2019;33:6442–55.
Highton J, Hessian PA, Stamp L. The rheumatoid nodule: peripheral or central to rheumatoid arthritis. Rheumatology. 2007;46:1385–7.
Highton J, Hung N, Hessian P, Wilsher M. Pulmonary rheumatoid nodules demonstrating features usually associated with synovial membrane. Rheumatology. 2007;46:811–4.
Stamp LK, Eason A, Lehnigk U, Highton J, Hessian PA. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arth Rheum. 2008;58:1601–8.
Liu H, Rohowsky-Kochan C. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signalling protein 1. J Interferon Cytokine Res. 2011;31:459–69.
Larousserie F, Pflanz S, Coulomb-L’Hermine A, Brousse N, Kastelein R, Cevergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Path. 2004;202:164–71.
Cao Y, Doodes PD, Glant TT, Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol. 2008;180:922–30.
Gong F, Pan Y-H, Huang X, Chen J, Xiao J, Zhu H. Interleukin-27 as a potential therapeutic target for rheumatoid arthritis: has the time come? Clin Rheumatol. 2013;32:1425–8.
Jones GW, Hill DG, Cardua A, Jones SA. Il-27: a double agent in the IL-6 family. Clin Exp Immunol. 2018;193:37–46.
Canete JD, Celis R, Yeremenko N, Sanmarti R, van Duivenvoorde L, Ramirez J, et al. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arth Res Ther. 2015;17:173. https://doi.org/10.1186/s13075-015-0688-0.
Batten M, Ramamoorrthi N, Kijavin NM, Ma CS, Cox J, Dengler HS, et al. IL-27 supports germinal centre function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med. 2010;201:2895–906.
Vijayan D, Mohd Redzwan N, Avery DT, Wirasinha RC, Brink R, Walters G, et al. IL-27 directly enhances germinal centre B cell activity and potentiates Lupus in sanroque mice. J Immunol. 2016;197:3008–17.
Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20:633–41.
Villarino AV, Larkin J, Saris CJ, Caton AJ, Lucas S, Wong T, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;15:7684–91.
Mehta AK, Gracias DT, Croft M. TNF activity and T cells. Cytokine. 2018;101:14–18.
Millier MJ, Stamp LK, Hessian PA. Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Sci Rep. 2018;7:17235. https://doi.org/10.1038/s41598-017-17619-0.
Acknowledgements
Thanks to Sam Smith-Bell for his help with IL6 and TNF expression data and Jill Drake for help with coordination of patient data. Histology support was provided by the Otago micro and nanoscale imaging unit. This work was supported by grants from the Health Research Council of New Zealand and an Otago Medical Research Foundation, Jack Thomson grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Millier, M.J., Lazaro, K., Stamp, L.K. et al. The contribution from interleukin-27 towards rheumatoid inflammation: insights from gene expression. Genes Immun 21, 249–259 (2020). https://doi.org/10.1038/s41435-020-0102-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41435-020-0102-z
This article is cited by
-
Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis
Arthritis Research & Therapy (2023)
-
Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration
Clinical Rheumatology (2023)
-
Plasma interleukin-23 and circulating IL-17A+IFNγ+ ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis
Arthritis Research & Therapy (2022)